论文部分内容阅读
对 30 3例冠心病患者随机分组 ,采用血液稀释 (下称血稀组 )及传统疗法 (下称对照组 )进行单盲对照临床研究。结果显示 ,与对照组比较 ,血稀组血液流变学指标 ,球结膜微循环指标、血小板聚集率、血脂等主要指标明显改善 (P<0 .0 5 ) ,心绞痛症状显效率为 6 5 .7% ,总有效率为 93.4% ,而对照组分别为 38.1%、 6 7.6 % ,两组均有显著性差异 (P<0 .0 1)。心电图改善血稀组显效率为 2 7.7% ,总有效率为 6 9.7% ,而对照组分别为 9.6 %、33.9% ,血稀组明显优于对照组 (P<0 .0 1)。未发现明显不良反应。
A total of 303 patients with coronary heart disease were randomly divided into two groups. One-blind controlled clinical trial was performed using hemodilution (referred to as blood thinning group) and conventional therapy (hereinafter referred to as control group). The results showed that compared with the control group, the indexes of hemorrheology, bulbar conjunctival microcirculation, platelet aggregation and blood lipids were significantly improved (P <0.05), and the effective rate of angina pectoris was 65%. 7%, the total effective rate was 93.4%, while the control group were 38.1%, 7.66%, both groups were significantly different (P <0.01). The electrocardiogram improved blood thinning group markedly effective rate of 2 7.7%, the total effective rate of 6 9.7%, while the control group were 9.6%, 33.9%, blood thinning group was significantly better than the control group (P <0. No obvious adverse reactions were found.